Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
40 hedge funds and large institutions have $138M invested in Global Cord Blood Corporation in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 11 closing their positions.
44% more call options, than puts
Call options by funds: $118K | Put options by funds: $82K
0.79% more ownership
Funds ownership: 16.82% → 17.61% (+0.79%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less capital invested
Capital invested by funds: $142M → $138M (-$4M)
7% less funds holding
Funds holding: 43 → 40 (-3)
27% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 11
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JCM
Jayhawk Capital Management
Shawnee,
Kansas
|
+$6.87M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.21M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$661K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$341K |
| 5 |
VF
Virtu Financial
New York
|
+$86K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Silphium Asset Management
London,
United Kingdom
|
-$1.42M |
| 2 |
Millennium Management
New York
|
-$601K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$279K |
| 4 |
Two Sigma Investments
New York
|
-$209K |
| 5 |
Renaissance Technologies
New York
|
-$170K |
CO Hedge Fund Activity: Q4 2018 in Review
40 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q4 2018, worth a combined $138M — down 2.8% from $142M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of CO and 8 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 8 added.
The largest buyer was Jayhawk Capital Management, adding an estimated $6.87M. The largest seller was Silphium Asset Management, exiting entirely with an estimated $1.42M sold.
- 40 institutional investors held Global Cord Blood Corporation (CO) as of Q4 2018, down from 43 in Q3 2018.
- Funds reported $138M of Global Cord Blood Corporation stock for Q4 2018, down 2.8% quarter-over-quarter.
- 8 funds opened new Global Cord Blood Corporation positions in Q4 2018 and 11 closed out, a net change of -3 holders.
- The largest Global Cord Blood Corporation buyer in Q4 2018 was Jayhawk Capital Management, an estimated $6.87M added.
- The largest Global Cord Blood Corporation seller in Q4 2018 was Silphium Asset Management, an estimated $1.42M sold.
Based on aggregated 13F filings for Q4 2018.